Retraction: Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation
- PMID: 27697993
- DOI: 10.1158/1078-0432.CCR-16-1914
Retraction: Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation
Retraction of
-
Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation.Clin Cancer Res. 2007 Jul 15;13(14):4280-90. doi: 10.1158/1078-0432.CCR-07-0835. Clin Cancer Res. 2007. Retraction in: Clin Cancer Res. 2016 Oct 1;22(19):4959. doi: 10.1158/1078-0432.CCR-16-1914. PMID: 17634558 Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
